Mesa Laboratories Inc
MLAB· Nasdaq
MLABMesa Laboratories Inc
Filed May 30, 2023 · 10-K · 60 days after period end · 0001437749-23-016028
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021 | Q4 2020 |
|---|---|---|---|---|
| Revenue | $55.59M | $58.88M | $37.96M | $34.21M |
| Net Income | $611.00K | -$1.78M | $3.92M | — |
| EPS Diluted | — | — | $0.74 | -$0.37 |
Mesa Laboratories Inc · CIK 724004 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Mar 31, 2023 · filed May 30, 2023 · 60 d after period end
